Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This objective of this study is to use sensitive methodology under controlled conditions to investigate the mechanisms by which fructose consumption contributes to excess fatty acid synthesis and elevations in blood glucose levels following consumption of meals containing fructose.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| High fructose meal, with fructose label | Experimental | 2-13C fructose incorporated into a meal with high fructose content |
|
| High fructose meal, with pyruvate label | Experimental | 2-13C pyruvate incorporated into a meal with high fructose content |
|
| Low fructose meal, with fructose label | Experimental | 2-13C fructose incorporated into a meal with low fructose content |
|
| Low fructose meal, with pyruvate label | Experimental | 2-13C pyruvate incorporated into a meal with low fructose content |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| High fructose, fructose labeled meal | Other | Liquid meal containing high fructose (16% of energy), labeled with 2-13C fructose |
|
| Measure | Description | Time Frame |
|---|---|---|
| Hepatic fractional de novo lipogenesis in triglyceride rich lipoprotein (TRL) | Measured by the detection of 13C carbons in TRL-palmitate from administered 13C labeled pyruvate or 13C labeled fructose. | 6 hours |
| Rate of appearance of UDP-glucose | An estimate of hepatic glycogen flux measured by administration of D1 galactose and acetaminophen | 6 hours |
| Rate of appearance of blood glucose from gluconeogenesis | Measured by the dilution method of labeled glucose | 6 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Serum triglyceride concentration | Fasting and postprandial serum triglyceride levels | 6 hours |
| Serum glucose concentration | Fasting and postprandial serum triglyceride levels |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jean-Marc Schwarz, PhD | Touro University, California | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Touro University California | Vallejo | California | 94592 | United States |
Not provided
| ID | Term |
|---|---|
| D007333 | Insulin Resistance |
| D018149 | Glucose Intolerance |
| ID | Term |
|---|---|
| D006946 | Hyperinsulinism |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| High fructose, pyruvate labeled meal | Other | Liquid meal containing high fructose (16% of energy), labeled with 2-13C pyruvate |
|
| Low fructose, fructose labeled meal | Other | Liquid meals containing low fructose (6% of energy), labeled with 2-13C fructose |
|
| Low fructose, pyruvate labeled meal | Other | Liquid meal containing low fructose (6% of energy), labeled with 2-13C pyruvate |
|
| 6 hours |
| Serum lactate concentration | Fasting and postprandial serum lactate levels | 6 hours |
| Serum insulin concentration | Fasting and postprandial insulin levels | 6 hours |
| Serum free fatty acid concentration | Fasting and postprandial fatty acid levels | 6 hours |
| Enteral (chylomicron) fractional de novo lipogenesis (DNL) | Measured by the detection of 13C carbons in chylomicron-palmitate from administered 13C labeled pyruvate or 13C labeled fructose. | 6 hours |
| Hepatic (VLDL) fractional de novo lipogenesis (DNL) | Measured by the detection of 13C carbons in VLDL-palmitate from administered 13C labeled pyruvate or 13C labeled fructose. | 6 hours |
| Extrasplanchnic fructose | Calculated using total plasma fructose, plasma 2-13C fructose enrichment, and endogenous fructose production | 6 hours |
| Whole body fructose oxidation | Measured by 13C atom % excess in exhaled breath, and VCO2 by indirect calorimetry | 6 hours |
| D006943 | Hyperglycemia |